Brimonidine tartrate and brinzolamide are two different medications that are prescribed together to treat certain eye diseases. Brimonidine tartrate is an alpha agonist that causes blood vessels in the eye to shrink, reducing swelling. Brinzolamide is a carbonic anhydrase inhibitor that stops the production of fluid in the eye, reducing intraocular pressure. Together, the two medications help to reduce swelling, reduce intraocular pressure, and reduce the risk of vision loss caused by certain ocular diseases.
Brimonidine tartrate and brinzolamide are used to treat certain ocular (eye) diseases, including open-angle glaucoma and ocular hypertension. The medications help to reduce the risk of vision loss caused by these conditions by reducing intraocular pressure and alleviating swelling in the eye.
| Brand Name | Azopres BR |
|---|---|
| Type | Ophthalmic Suspension |
| Weight | 1%+0.2% |
| Generic | Brinzolamide + Brimonidine Tartrate |
| Manufacturer | Ibn Sina Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Brimonidine tartrate works by activating certain receptors (alpha-2 receptors) to reduce the amount of fluid that accumulates in the eye, thereby reducing the intraocular pressure. Brinzolamide works by blocking an enzyme (carbonic anhydrase) which helps to reduce the production of fluids in the eye, thereby reducing the intraocular pressure.
Brimonidine tartrate and brinzolamide typically start to work within one to three hours after being applied. The full effects of the medications usually take a few days to become apparent.
Brimonidine tartrate and brinzolamide are both well absorbed when applied topically to the eyes. The medications are then distributed to the parts of the eye where they are needed most.
Brimonidine tartrate and brinzolamide are both eliminated from the body primarily through the kidneys. Some of the medications may also be eliminated through the bile.
Brimonidine tartrate and brinzolamide are typically applied topically to the eye as part of a combination eyedrop. The combination eyedrops come in several strengths and formulations, and the dosage and administration instructions may vary depending on the specific product. In general, it is recommended to apply the eyedrops once in the morning and once in the evening, as directed by your doctor.
Common side effects associated with brimonidine tartrate and brinzolamide include burning, stinging, and droopy eyelids. Other side effects may include dry eyes, blurred vision, eye pain, redness, and irritability.
If applied to areas other than the eye, brimonidine tartrate and brinzolamide may be toxic. Symptoms of toxicity can include difficulty breathing, intense burning, and skin irritation. Seek medical attention immediately if you experience any of these symptoms.
Before using brimonidine tartrate and brinzolamide, you should inform your doctor if you have any allergies, are using any other medications (such as topical steroids or nonsteroidal anti-inflammatory drugs), or have any other health concerns (such as narrow-angle glaucoma). Do not wear contact lenses while you are using this medication.
Brimonidine tartrate and brinzolamide may interact with other medications, so tell your doctor or pharmacist if you are using any other drugs. This medication should also not be used with certain medications due to potentially dangerous interactions. Be sure to tell your doctor about all the medications you are taking, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Brimonidine tartrate and brinzolamide should not be used if you have severe heart disease, liver disease, or kidney disease. If you have a narrow-angle glaucoma, the medication should only be used with caution and under the supervision of your doctor.
Brimonidine tartrate and brinzolamide may interact with other drugs and should not be used with certain medications, such as: systemic beta-blockers, alpha-adrenergic blockers, calcium channel blockers, miotics, sympathomimetics, and other topical ocular medications.
Brimonidine tartrate and brinzolamide may interact with certain foods. It is recommended to avoid drinking alcohol while using this medication, as it can increase the side effects. You should also avoid taking other medications that contain alcohol while using brimonidine tartrate and brinzolamide.
Brimonidine tartrate and brinzolamide should not be used during pregnancy unless the potential benefits outweigh the risks. If you are pregnant, you should tell your doctor before using this medication. It is not known if the medication can pass into breastmilk.
Brimonidine tartrate and brinzolamide should not be used while breastfeeding unless the potential benefits outweigh the risks. It is not known if the medication can pass into breastmilk.
There have been reports of overdose with brimonidine tartrate and brinzolamide. Symptoms of an overdose can include severe nausea, vomiting, diarrhea, drowsiness, and disorientation. Call your doctor or go to the nearest emergency room immediately if you think you have taken an overdose of this medication.
Brimonidine tartrate and brinzolamide should not be used if you are allergic to any of its ingredients or if you have narrow-angle glaucoma. Do not use the medication if the bottle tip is punctured or broken.
For best results, brimonidine tartrate and brinzolamide should be used exactly as prescribed by your doctor. Be sure to wash your hands before and after using the medication. Tilt your head back and pull down the lower lid of the affected eye. Squeeze the indicated number of drops into the pocket formed by the lower eyelid. Close your eyes for 1–2 minutes with your head tilted down, without blinking or squeezing the eyes. After 1–2 minutes, wipe away any excess liquid with a tissue.
Brimonidine tartrate and brinzolamide should be stored at room temperature, away from heat and moisture. Do not store the medication in the bathroom. Do not keep near open flames or in very hot or cold temperatures. Do not expose to sunlight.
The volume of distribution for brimonidine tartrate and brinzolamide is unknown.
The half-life of brimonidine tartrate and brinzolamide is approximately 6 hours.
The clearance of brimonidine tartrate and brinzolamide is unknown.
See in details version Azopres BR Ophthalmic Suspension 1%+0.2% also Azopres BR Ophthalmic Suspension 1%+0.2% in bangla